Clinical Scenario:
A 10-year-old girl with early puberty has an advanced bone age and compromised predicted adult height. MRI of the brain shows no structural CNS abnormality. Biochemical testing confirms central activation of the hypothalamic-pituitary-gonadal axis. Which treatment is most appropriate to preserve her remaining height potential?
A. GnRH agonist
B. Growth hormone alone
C. Oral estrogen
D. Observation
E. Oophorectomy
Correct answer & Explanation:
Answer: A. GnRH agonist
Discussion
A GnRH agonist such as leuprolide is the standard treatment for appropriately selected children with central precocious puberty (CPP). Continuous administration initially stimulates and then desensitizes pituitary GnRH receptors, suppressing LH and FSH secretion and consequently reducing gonadal sex-steroid production.
Suppression of pubertal sex steroids slows accelerated bone maturation, allowing additional time for linear growth and potentially improving final adult height, particularly when puberty has begun sufficiently early and predicted adult height is compromised.
Growth hormone alone does not suppress the underlying pubertal process. Estrogen would accelerate epiphyseal maturation and therefore worsen the loss of remaining growth potential. Observation may be appropriate in selected children with slowly progressive puberty and no significant compromise of adult height, but is not appropriate when there is substantial advancement of bone age and compromised predicted height.
Exam pearl:
In central precocious puberty with rapid progression, markedly advanced bone age, or compromised adult height, treatment with a long-acting GnRH agonist suppresses pubertal progression and preserves growth potential.
